Surmodics | SRDX - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Abbott USD 5.86B 675M 2026-03
Align Technology USD 736.59M 53M 2026-03
Anika Therapeutics USD 19.18M 3.6M 2025-12
Arrowhead Research USD 256.47M 228.7M 2025-09
Artivion USD 73.14M 1.25M 2025-12
Baxter International USD 891M 314M 2026-03
Boston Scientific USD 3.61B 64M 2026-03
EDAP TMS EUR 5.97M 850K 2025-09
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Haemonetics USD 202.39M 7.64M 2025-12
Heron Therapeutics USD 29.47M 3.17M 2025-12
J&J USD 17.24B 642M 2026-03
Merit Medical Systems USD 184.8M 10.56M 2026-03
Mesa Laboratories USD 39.75M 4.3M 2024-12
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Option Care Health USD 262.01M 20.88M 2026-03
Stryker USD 3.81B 675M 2026-03
Surmodics USD 20.08M 31.62M 2025-06
Trinity Biotech USD 6.47M 1.59M 2025-09